Anne Borgman, M.D.
Board Member
NextCure, Inc. (NXTC)Equibles does not estimate personal net worth.
Get an email with a short summary when NextCure, Inc. publishes a filing, an earnings call transcript or a press release.
Get NXTC alertsAbout Anne Borgman, M.D.
Anne Borgman, M.D. is recorded as Board Member at NextCure, Inc. (NXTC) since June 18, 2026. NextCure, Inc. reported in an 8-K filed June 25, 2026 that Anne Borgman, M.D. was appointed Class I Director, effective June 18, 2026. NextCure, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at NextCure, Inc. includes Michael Richman (CEO), Steven P. Cobourn (CFO), Timothy Mayer (COO) and 4 others.
“(i) elected two Class I members of the Board, each to serve for a three-year term expiring at the Company's 2029 Annual Meeting of Stockholders and until such director's earlier death, resignation, or removal from the Board”
Affiliation history
-
Current
2026-06-18–present
Company network
Leadership on record at NextCure, Inc.
- Michael Richman CEO
- Steven P. Cobourn CFO
- Timothy Mayer COO
- Kevin G. Shaw General Counsel
- Anne Borgman Board Member
- Ellen Feigal Board Member
- John G. Houston, PH.D. Board Member